ASXL1 and myeloproliferative disorder: A similar paired analysis of transformed MPN-BP showed that mutations in chromatin modification (ASXL1, EZH2), RNA splicing (SRSF2), and signaling pathways (CBL, NF1, FLT3, RAS) are enriched in the blast phase [36].